期刊文献+

糖尿病视网膜病变早期诊断技术及其应用 被引量:9

Techniques and application of early diagnosis of diabetic retinopathy
下载PDF
导出
摘要 糖尿病视网膜病变(DR)是一种高血糖引起的,以视网膜微血管损伤、神经退行性病变等为特征的临床常见疾病。近年来随着新技术的发展,手持式免散瞳视觉电生理诊断设备(RETeval)、光学相干断层扫描(OCT)及光学相干断层扫描血管成像(OCTA)技术凭借其无创性、可定量、方便快捷等优势已成为研究的热点及DR早期诊断的重要辅助手段。本文就RETeval、OCT及OCTA的原理及其在DR中的应用进行综述。 Diabetic retinopathy(DR)is a common clinical condition caused by hyperglycemia,leading to retinal microvascular damage and neurodegeneration.With the development of advanced technologies,handheld electrophysiology(RETeval),optical coherence tomography(OCT)and optical coherence tomography angiography(OCTA)have been extensively studied and applied in early diagnosis of DR.These technologies are non-invasive and quantifiable,assisting in DR diagnosis in a fast and convenient manner.In this review,the principles and applications of RETeval,OCT and OCTA will be discussed in detail.
作者 尹玉如 赵博军 Yu-Ru Yin;Bo-Jun Zhao(Shandong University,Jinan 250100,Shandong Province,China;Department of Ophthalmology,Shandong Provincal Hospital,Jinan 250021,Shandong Province,China)
出处 《国际眼科杂志》 CAS 北大核心 2022年第3期438-442,共5页 International Eye Science
基金 山东省自然科学基金项目(No.ZR2019MH111)。
关键词 手持式免散瞳视觉电生理诊断设备 光学相干断层扫描 光学相干断层扫描血管成像 糖尿病视网膜病变 RETeval optical coherence tomography optical coherence tomography angiography diabetic retinopathy
  • 相关文献

参考文献4

二级参考文献78

  • 1Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalenceof diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14[PMID: 19896746 DOI: 10.1016/j.diabres.2009.10.007].
  • 2World Health Organization. Diabetes Action Now: An Initiativeof the World Health Organization and the International DiabetesFederation. Switzerland: World Health Organization, 2004.
  • 3Stefánsson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E.Screening and prevention of diabetic blindness. Acta OphthalmolScand 2000; 78: 374-385 [PMID: 10990036 DOI: 10.1034/j.1600-0420.2000.078004374.x].
  • 4Prokofyeva E, Zrenner E. Epidemiology of major eye diseasesleading to blindness in Europe: a literature review. Ophthalmic Res2012; 47: 171-188 [PMID: 22123077 DOI: 10.1159/000329603].
  • 5Hammes HP. Optimal treatment of diabetic retinopathy. Ther AdvEndocrinol Metab 2013; 4: 61-71 [PMID: 23626903 DOI: 10.1177/2042018813477886].
  • 6Deutsche DG. Nationale VersorgungsLeitlinie Typ-2-DiabetesPr-vention und Therapie von Netzhautkomplikationen. Berlin:Bundes-rztekammer (B-K), 2010: 1-42.
  • 7Giani G, Janka HU, Hauner H, Standl E, Schiel R, Neu, A.Epidemiologie und Verlauf des Diabetes mellitus in Deutschland.Evidenzbasierte Leitlinie DDG-Aktualisierung 2004; 5: 1-12.
  • 8Nentwich MM, Ulbig M. Diabetische Retinopathie. DerDiabetologe 2010; 6: 491-502 [DOI: 10.1007/s11428-010-0605-8].
  • 9Kramer CK, Retnakaran R. Concordance of retinopathy andnephropathy over time in Type 1 diabetes: an analysis of data fromthe Diabetes Control and Complications Trial. Diabet Med 2013;30: 1333-1341 [PMID: 23909911 DOI: 10.1111/dme.12296].
  • 10Karlberg C, Falk C, Green A, Sj-lie AK, Grauslund J. Proliferativeretinopathy predicts nephropathy: a 25-year follow-upstudy of type 1 diabetic patients. Acta Diabetol 2012; 49: 263-268[PMID: 21688016 DOI: 10.1007/s00592-011-0304-y].

共引文献70

同被引文献88

引证文献9

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部